Skip to main content
SpringerLink
Log in

Recent Advances in Giant Cell Myocarditis

  • Chapter
Cardiomyopathies and Heart Failure

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 248))

  • 129 Accesses

Abstract

In the past decade, understanding of the natural history and effect of immunosuppression and transplantation on idiopathic giant cell myocarditis (IGCM) has advanced significantly. IGCM was first described by Sergius Saltikow in a 37 year old man who died suddenly.1 Subsequently dozens of case reports and a few small series documented that IGCM is usually a fatal disorder that generally affects young, otherwise healthy individuals, although, a minority of cases occur in association with autoimmune disorders or thymoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Saltykow S. Uber Diffuse Myokarditis. Virchows Archiv fur Pathologische Anatomie. 1905;182:1–39.

    Article  Google Scholar 

  2. Ren H, Poston RS, Jr., Hruban RH, et al. Long Survival with Giant Cell Myocarditis. Mod Pathol 1993;6:402–407.

    PubMed  CAS  Google Scholar 

  3. Frustaci A, Chimenti C, Peironi M, et al. Giant Cell Myocarditis Responding to Immunosuppressive Therapy. Chest 2000;117:905–907.

    Article  PubMed  CAS  Google Scholar 

  4. Amidon T, Baldwin J, George E. Eosinophilia-Myalgia Syndrome and Giant Cell Myocarditis: A Case Report and Therapeutic Approach. Heart Disease. 1999; 1:66–67.

    PubMed  CAS  Google Scholar 

  5. Costanzo-Nordin M, Silver M, O’Connell J, et al. Giant Cell Myocarditis: Dramatic Hemodynamic Histologic Improvement with Immunosuppressive Therapy. Eur Heart J 1987;J;271–274.

    Article  Google Scholar 

  6. Desjardins V, Pelletier G, Leung TK, et al. Successful Treatment of Severe Heart Failure Caused by Idiopathic Giant Cell Myocarditis. Can J Cardiol 1992;8:788–792.

    PubMed  CAS  Google Scholar 

  7. Levy N, Olson L, Weyand C, et al. Histologic and Cytokine Response to Immunosuppression in Giant Cell Myocarditis. Annals of Internal Medicine 1998;128:648–650.

    PubMed  CAS  Google Scholar 

  8. Menghini VV, Savchenko V, Olson LJ, et al. Combined Immunosuppression for the Treatment of Idiopathic Giant Cell Myocarditis. Mayo Clin Proc 1999;74:1221–1226.

    Article  PubMed  CAS  Google Scholar 

  9. Cooper LT, Shabetai R. Immunosuppressive Therapy for Myocarditis. N Engl J Med 1995;333:1713–1714.

    Article  PubMed  Google Scholar 

  10. Cooper LT, Berry, G.J., Shabetai, R. Idiopathic Giant-Cell Myocarditis-Natural History and Treatment. N Engl J Med 1997;336:1860–1866.

    Article  PubMed  Google Scholar 

  11. Laufs H, Nigrovic P, Schneider L, et al. Giant Cell Myocarditis in a 12-Year-Old Girl with Common Variable Immunodeficiency. Mayo Clinic Proceedings 2002;77:92–96.

    Article  PubMed  Google Scholar 

  12. Goldberg GM. Myocarditis of the Giant-Cell Type in an Infant. Am J Clin Pathol 1955;25:510–513.

    PubMed  CAS  Google Scholar 

  13. Whitehead R. Isolated Myocarditis. Brit Heart J 1965;27:220–230.

    Article  PubMed  CAS  Google Scholar 

  14. Nash C, Panaccione R, Sutherland L, et al. Giant Cell Myocarditis in a Patient with Crohn’s Disease, Treated with Etanercept-A Tumor Necrosis Factor-Alpha Antagonist. Canadian J Gastroenterology 2001;15:607–611.

    CAS  Google Scholar 

  15. Kodama M, Matsumoto Y, Fujiwara M, et al. A Novel Experimental Model of Giant Cell Myocarditis Induced in Rats by Immunization with Cardiac Myosin Fraction. Clin Immunol Immunopathol 1990;57:250–262.

    Article  PubMed  CAS  Google Scholar 

  16. Okura Y, Yamamoto T, Goto S, et al. Characterization of Cytokine and inos mrna Expression In Situ During the Course of Experimental Autoimmune Myocarditis in Rats. J Mol Cell Cardiol 1997;29:491–502.

    Article  PubMed  CAS  Google Scholar 

  17. Kodama M, Matsumoto Y, Fujiwara M. In Vivo Lymphocyte-Mediated Myocardial Injuries Demonstrated by Adoptive Transfer of Experimental Autoimmune Myocarditis. Circulation 1992;85:1918–1926.

    Article  PubMed  CAS  Google Scholar 

  18. Hirono S, Islam MO, Nakazawa M, et al. Expression of Inducible Nitric Oxide Synthetase in Rat Experimental Autoimmune Myocarditis with Special Reference to Changes in Cardiac Hemodynamics. Circ Res 1997;80:11–20.

    Article  PubMed  CAS  Google Scholar 

  19. Badorff C, Fichtlscherer B, Rhoads R, et al. Nitric Oxide Inhibits Dystrophin Proteolysis by Coxsackieviral Protease 2A Through S-Nitrosylation: A Protective mechanism against enteroviral cardiomyopathy. Circulation 2000;102:2276–2281.

    Article  PubMed  CAS  Google Scholar 

  20. Shioji K, Kishimoto C, Nakayama Y, et al. Strain Difference in Rats with Experimental Giant Cell Myocarditis. Jpn Cire J 2000;64:283–286.

    Article  CAS  Google Scholar 

  21. Litovsky SH, Burke AP, Virmani MD. Giant Cell Myocarditis: An Entity Distinct from Sarcoidosis Characterized by Multiphasic Myocyte Destruction by Cytotoxic T Cells and Histiocytic Giant Cells. Mod Pathol 1996;9:1126–1134.

    PubMed  CAS  Google Scholar 

  22. Laufs H, Nigrovic P, Schneider L, et al. Giant Cell Myocarditis in a 12-Year-Old Girl with Common Variable Immunodeficiency. Mayo Clinic Proceedings 2002;77:92–96.

    Article  PubMed  Google Scholar 

  23. Chow LH, Ye Y, Linder J, et al. Phenotypic Analysis of Infiltrating Cells in Human Myocarditis. An Immunohistochemical Study in Paraffin-Embedded Tissue. Arch Pathol Lab Med 1989;113:1357–1362.

    PubMed  CAS  Google Scholar 

  24. Ariza A, Lopez MD, Mate JL, et al. Giant Cell Myocarditis: Monocytic Immunophenotype of Giant Cells in a Case Associated with Ulcerative Colitis. Hum Pathol 1995;26:121–123.

    Article  PubMed  CAS  Google Scholar 

  25. Cooper LT, Jr., Berry GJ, Rizeq M, et al. Giant Cell Myocarditis. J Heart Lung Transplant 1995;14:394–401.

    PubMed  Google Scholar 

  26. Pyun KS, Kim YH, Katzenstein RE, et al. Giant Cell Myocarditis. Light and Electron Microscopic Study. Arch Pathol 1970;90:181–188.

    PubMed  CAS  Google Scholar 

  27. Tubbs RR, Sheibani K, Hawk WA. Giant Cell Myocarditis. Arch Pathol Lab Med 1980;104:245–246.

    PubMed  CAS  Google Scholar 

  28. Zhang S, Kodama M, Hanawa H, et al. Effects of Cyclosporine, Prednisolone and Aspirin on Rat Autoimmune Giant Cell Myocarditis. J Am Coll Cardiol 1993 ;21:1254–1260.

    Article  PubMed  CAS  Google Scholar 

  29. Hanawa H, Kodama M, Inomata T, et al. Anti-Alpha Beta T Cell Receptor Antibody Prevents the Progression of Experimental Autoimmune Myocarditis. Clin Exp Immunol 1994;96:470–475.

    Article  PubMed  CAS  Google Scholar 

  30. Kodama M, Hanawa H, Saeki M, et al. Rat Dilated Cardiomyopathy after Autoimmune Giant Cell Myocarditis. Circ Res 1994;75:278–284.

    Article  PubMed  CAS  Google Scholar 

  31. Cooper L, Okura Y. Idiopathic Giant Cell Myocarditis. Current treatment options in Cardiovascular Medicine 2001 ;3:463–467.

    Article  PubMed  Google Scholar 

  32. Starling R, Galbraith T, Baker P, et al. Successful Management of Acute Myocarditis with Biventricular Assist Devices and Cardiac Transplantation. Am J Cardiol 1988;62:341–343.

    Article  PubMed  CAS  Google Scholar 

  33. Reiss N, el-Banayosy A, Posival H, et al. Management of Acute Fulminant Myocarditis using Circulatory Support Systems. Artif Organs 1996;20:964–970.

    Article  PubMed  CAS  Google Scholar 

  34. Brilakis E, Olson LJ, Daly RC, et al. Role of Ventricular Assist Device Support as a Bridge to Transplantation in Giant Cell Myocarditis. J Heart Lung Transplant 1999;18:31.

    Article  Google Scholar 

  35. Scott R, Ratliff N, Starling R, et al. Recurrence of Giant Cell Myocarditis in Cardiac Allograft. J Heart Lung Transplant 2001;20:375–380.

    Article  PubMed  CAS  Google Scholar 

  36. Nieminen MS, Salminen US, Taskinen E, et al. Treatment of Serious Heart Failure by Transplantation in Giant Cell Myocarditis Diagnosed by Endomyocardial Biopsy. J Heart Lung Transplant 1994;13:543–545.

    PubMed  CAS  Google Scholar 

  37. Briganti E, Esmore DS, Federman J, et al. Successful Heart Transplantation in a Patient with Histopathologically Proven Giant Cell Myocarditis. J Heart Lung Transplantation 1993;12:880–881.

    CAS  Google Scholar 

  38. Lamelle C, Vanhaecke J, Van de Werf F, et al. Cardiac Transplantation in Giant Cell Myocarditis. A Case Report. Acta Cardiologica 1994;49:279–286.

    Google Scholar 

  39. Kong G, Madden B, Spyrou N, et al. Response of Recurrent Giant Cell Myocarditis in a Transplanted Heart to Intensive Immunosuppression. Eur Heart J 1991;12:554–557.

    PubMed  CAS  Google Scholar 

  40. Gries W, Farkas D, Winters GL, et al. Giant Cell Myocarditis: First Report of Disease Recurrence in the Transplanted Heart. J Heart Lung Transplant 1992;11:370–374.

    PubMed  CAS  Google Scholar 

  41. Grant SC. Myocarditis in a Transplanted Heart. Eur Heart J 1993; 14:1437.

    Article  PubMed  CAS  Google Scholar 

  42. Grant SC. Recurrent Giant Cell Myocarditis after Transplantation. J Heart Lung Transplant 1993;12:155–156.

    PubMed  CAS  Google Scholar 

  43. Cooper LT, Berry GJ, Tazelaar H, et al. A Comparison of Post-Transplantation Survival in Giant Cell Myocarditis and Cardiomyopathy Patients. J Am Coll Cardiol 1998;29:251A.

    Google Scholar 

  44. Okada R, Wakafuji S. Myocarditis in Autopsy. Heart Vessels Suppl 1985;1:23–29.

    Article  PubMed  CAS  Google Scholar 

  45. Daniels P, Berry G, Tazelaar H, et al. Giant Cell Mycocarditis as a Manifestaion of Drug Hypersensitivity. Cardiovasc Pathol 2000;9:287–291

    Article  PubMed  CAS  Google Scholar 

  46. Ishikawa H, Kaneko H, Watanabe H, et al. Giant Cell Myocarditis in Association with Drug-Induced Skin Eruption. Acta Pathol Jpn 1987;37:639–644.

    PubMed  CAS  Google Scholar 

  47. Truica C, Hansen C, Garvin D, et al. Idiopathic Giant Cell Myocarditis after Autologous Hematopoietic Stem Cell Transplantation and Interleukin-2 Immunotherapy: A Case Report. Cancer 1998;83:1231–1236.

    Article  PubMed  CAS  Google Scholar 

  48. Klein BR, Hedges TR 3rd, Dayal Y, et al. Orbital Myositis and Giant Cell Myocarditis. Neurology. 1989;39:988–990.

    Article  PubMed  CAS  Google Scholar 

  49. De Jongste MJ, Oosterhuis HJ, Lie KI. Intractable Ventricular Tachycardia in a Patient with Giant Cell Myocarditis, Thymoma and Myasthenia Gravis. Int J Cardiol 1986;13:374–378.

    Article  PubMed  Google Scholar 

  50. Burke JS, Medline NM, Katz A. Giant Cell Myocarditis and Myositis. Associated with Thymoma and Myasthenia Gravis. Arch Pathol 1969;88:359–366.

    PubMed  CAS  Google Scholar 

  51. Kloin JE. Pernicious Anemia and Giant Cell Myocarditis. New Association. Am J Med 1985;78:355–360.

    Article  PubMed  CAS  Google Scholar 

  52. Mckeon J, Haagsma B, Bett JH, et al. Fatal Giant Cell Myocarditis after Colectomy for Ulcerative Colitis. Am Heart J 1986;111:1208–1209.

    Article  PubMed  CAS  Google Scholar 

  53. Weidhase A, Grone HJ, Unterberg C, et al. Severe Granulomatous Giant Cell Myocarditis in Wegener’s Granulomatosis. Klin Wochenschr 1990;68:880–885.

    Article  PubMed  CAS  Google Scholar 

  54. Palmer H, Michael I. Giant-Cell Myocarditis with Multiple Organ Involvement. Arch Intern Med 1965;116:444–447.

    Article  PubMed  CAS  Google Scholar 

  55. Mason JW, O’Connell JB, Herskowitz A, et al. A Clinical Trial of Immunosuppressive Therapy for Myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995;333:269–275.

    Article  PubMed  CAS  Google Scholar 

  56. Davidoff R, Palacios I, Southern J, et al. Giant Cell Versus Lymphocytic Myocarditis. A Comparison of their Clinical Features and Long-Term Outcomes. Circulation 1991;83:953–961.

    Article  PubMed  CAS  Google Scholar 

  57. Cooper LT Jr, Berry GJ, Shabetai R. Giant Cell Myocarditis: Distinctions from Lymphocytic Myocarditis and Cardiac Sarcoidosis. J Heart Failure 1997;4:227.

    Google Scholar 

  58. Shields R, Tazelaar HD, Berry GJ, et al. The Sensitivity of Right Ventricular Endomyocardial Biopsy for Idiopathic Giant Cell Myocarditis. J Cardiac Failure 2002;8:74–78.

    Article  Google Scholar 

  59. Narula J, Khaw BA, Dec GW, et al. Diagnostic Accuracy of Antimyosin Scintigraphy in Suspected Myocarditis. J Nuc Cardiol 1996;3:371–381.

    Article  CAS  Google Scholar 

  60. Lauer B, Padberg K, Schultheiss H-P, et al. Autoantibodies Against Human Ventricular Myosin in Sera of Patients with Acute and Chronic Myocarditis. J Am Coll Cardiol 1994;23:146–153.

    Article  PubMed  CAS  Google Scholar 

  61. Martin A, Webber S, Fricker J, et al. Acute Myocarditis. Rapid Diagnosis by PCR in Children. Circulation 1994;90:330–339.

    Article  PubMed  CAS  Google Scholar 

  62. Shimada T, Shimada K, Sakane T, et al. Diagnosis of Cardiac Sarcoidosis and Evaluation of the Effects of Steroid Therapy by Gadolinium-DTPA-Enhanced Magnetic Resonance Imaging. Am J Med 2001 ;110:520–527.

    Article  PubMed  CAS  Google Scholar 

  63. Hirose Y, Ishida Y, Hayashida K, et al. Myocardial Involvement in Patients with Cardiac Sarcoidosis: An Analysis of 75 Patients. Clinical Nuclear Medicine 1994;19:522–556.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA

    Leslie T. Cooper Jr. MD (Consultant)

Authors
  1. Leslie T. Cooper Jr. MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan

    Akira Matsumori MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Cooper, L.T. (2003). Recent Advances in Giant Cell Myocarditis. In: Matsumori, A. (eds) Cardiomyopathies and Heart Failure. Developments in Cardiovascular Medicine, vol 248. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-9264-2_29

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-9264-2_29

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4865-8

  • Online ISBN: 978-1-4419-9264-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation